ArticleAlzheimer's & dementia (New York, N. Y.)

Plasma amyloid beta biomarkers predict amyloid positivity and longitudinal clinical progression in mild cognitive impairment.

Takuya Ataka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.